A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
Clinical trial NCT04242446 · COMPLETED
Trial details
- NCT number
- NCT04242446
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-19
- Primary completion
- 2022-04-07
- Enrollment
- 505
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.